Jasper Therapeutics reports promising results for Briquilimab in Chronic Urticaria treatment

Jasper Therapeutics, Inc., a biotechnology company specializing in treatments for mast cell-driven diseases, has released groundbreaking preliminary results from its BEACON Phase 1b/2a study. The ... Read More